Family Practice, Internal Medicine, Manufacturing and Primary Care

Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement

Physician's Weekly

JULY 1, 2025

TUESDAY, July 1, 2025 (HealthDay News) — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 in the Annals of Internal Medicine. Bruno Linetzky, M.D., All rights reserved.

Internal Medicine

Internal Medicine Diabetes Manufacturing Complication

Synthetic Dyes Present in 19 Percent of U.S. Food Products

Physician's Weekly

JULY 3, 2025

manufacturers in 2020. Dunford, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues examined the use of synthetic dyes in U.S. foods and beverages sold by the top 25 U.S.

Primary Care Digest

Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement

Synthetic Dyes Present in 19 Percent of U.S. Food Products

Stay Connected